What Definium Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 6 | 15 |
| Total trades | 23 | 37 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 1,391,885 | 2,251,885 |
| Disposed | 77,154 | 207,751 |
| Net activity | +1,314,731 | +2,044,134 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Barrow Robert | Chief Executive Officer | Sep 03 | Open-market sale · S | −19,023 | $37.94 | −$722K | 1,494,640 |
| Barrow Robert | Chief Executive Officer | Sep 02 | Grant / award · A | +40,000 | — | — | 1,513,663 |
| Wiley Matthew T. | Chief Commercial Officer | Aug 12 | Grant / award · A | +62,500 | — | — | 237,133 |
| Roberts Brandi | Chief Financial Officer | Aug 12 | Grant / award · A | +62,500 | — | — | 271,987 |
| Karlin Dan | Chief Medical Officer | Aug 12 | Grant / award · A | +100,000 | — | — | 603,282 |
| Barrow Robert | Chief Executive Officer | Aug 12 | Grant / award · A | +375,000 | — | — | 1,473,246 |
| Sullivan Mark | Chief Legal Officer | Aug 12 | Grant / award · A | +62,500 | — | — | 383,071 |
| Wiley Matthew T. | Chief Commercial Officer | Jun 25 | Open-market sale · S | −2,867 | $45.03 | −$129K | 174,633 |
| Roberts Brandi | Chief Financial Officer | Jun 25 | Open-market sale · S | −3,013 | $45.03 | −$136K | 209,487 |
| Barrow Robert | Chief Executive Officer | Jun 25 | Open-market sale · S | −29,208 | $45.03 | −$1.32M | 1,098,246 |
| Karlin Dan | Chief Medical Officer | Jun 25 | Open-market sale · S | −10,035 | $45.03 | −$452K | 503,282 |
| Sullivan Mark | Chief Legal Officer | Jun 25 | Open-market sale · S | −13,008 | $45.03 | −$586K | 320,571 |
| Karlin Dan | Chief Medical Officer | Jun 22 | Grant / award · A | +100,000 | — | — | 513,317 |
| Sullivan Mark | Chief Legal Officer | Jun 22 | Grant / award · A | +62,500 | — | — | 333,579 |
| Roberts Brandi | Chief Financial Officer | Jun 22 | Grant / award · A | +62,500 | — | — | 212,500 |
| Barrow Robert | Chief Executive Officer | Jun 22 | Grant / award · A | +375,000 | — | — | 1,127,454 |
| Wiley Matthew T. | Chief Commercial Officer | Jun 22 | Grant / award · A | +62,500 | — | — | 177,500 |
| Bruhn Suzanne Louise | Director | Jun 11 | Grant / award · A | +4,666 | — | — | 24,289 |
| Krebs Andreas | Director | Jun 11 | Grant / award · A | +4,666 | — | — | 19,773 |
| Adsett Roger | Director | Jun 11 | Grant / award · A | +3,555 | — | — | 3,555 |
Loading...